As of December 31, 2024, Achieve reported $34.4 million in ... plans and potential for market introduction by the end of Q2 2025. Successful completion of key milestones in the ORCA-OL clinical ...
Appointed New Chief Financial Officer In December 2024, Mark Oki was appointed ... for smoking cessation in Q2 2025. Achieve has also conducted a successful End-of-Phase 2 meeting with the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback